Life-span cognitive activity, neuropathologic burden, and cognitive aging
35% in persons with cancer. This observation suggests partially alternative modalities of human senescence.
See p. 322
From editorialists Roe & Behrens: ".regardless of the particular mechanism underlying the relationship, if future research confirms that the development of cancer and AD are inversely associated, this knowledge may help in gaining a better understanding of and developing new treatments for both diseases." See p. 310 Differentiating primary progressive aphasias in a brief sample of connected speech A brief sample of connected speech was elicited from 62 persons drawn from 3 subgroups of patients with primary progressive aphasia (PPA): nonfluent/agrammatic, logopenic, and semantic. The subgroups were distinguished by easily quantifiable features of speech production. This simple protocol may aid in the differential diagnosis of PPA syndromes. Some recently emerging neurologic diseases of abnormal protein glycosylation cause congenital myasthenic syndromes. This paper reports on 11 patients with 12 novel mutations in glutamine-fructose-6-phosphate transaminase 1 (GFPT1) harboring hypoplastic endplates and varied defects of neuromuscular transmission. One patient had loss of the musclespecific GFPT1 exon and autophagic myopathy. In 550 children in pediatric ICUs, EEG monitoring identified electrographic seizures in 30%. Electrographic status epilepticus occurred in 38% and was associated with greater odds of inhospital death after multivariable analysis. Further study is needed to determine whether seizure identification and management could serve as a neuroprotective strategy.
See p. 383
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